Vis-Rx Post-Market Evaluation

NCT04533503 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 257

Last updated 2025-03-20

No results posted yet for this study

Summary

Post-market clinical evaluation of the Gentuity High-Frequency Optical Coherence Tomography (HF-OCT) System and the Vis-Rx Micro-Imaging Catheter for use in Percutaneous Coronary Intervention (PCI) procedures.

Conditions

Interventions

DEVICE

HF-OCT Imaging with the Vis-Rx Micro-Imaging Catheter

Intracoronary HF-OCT imaging of the target lesion(s) during the procedure.

Sponsors & Collaborators

  • Gentuity, LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-22
Primary Completion
2023-01-25
Completion
2023-01-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04533503 on ClinicalTrials.gov